CD8A and type 2 diabetes mellitus: Our novel finding with impaired CFR in patients with a reduced number of circulating CD8-IL21R+ T cells add additional important knowledge currently lacking in the understanding of the cardiovascular complications associated with T2D potentially aiding in the contradictory data around IL-21 in vasculature complications.